US Stock MarketDetailed Quotes
KPRX Kiora Pharmaceuticals
- 3.5700
- -0.0900-2.46%
Close Oct 1 16:00 ET
10.60MMarket Cap-616P/E (TTM)
3.6900High3.4717Low20.53KVolume3.6700Open3.6600Pre Close72.96KTurnover1.51%Turnover RatioLossP/E (Static)2.97MShares8.982052wk High0.32P/B4.84MFloat Cap3.000052wk Low--Dividend TTM1.36MShs Float189000.0000Historical High--Div YieldTTM5.96%Amplitude3.0000Historical Low3.5530Avg Price1Lot Size
Kiora Pharmaceuticals Stock Forum
Sign in to post a comment
$Kiora Pharmaceuticals (KPRX.US)$ 4: Statement of changes in beneficial ownership of securities-Director Shapiro Aron bought 3K shares at 3.60 PS
SEC· 41 mins ago
SEC· 41 mins ago
3
$Kiora Pharmaceuticals (KPRX.US)$ Officer Strem Brian M. purchased 3,000 shares of common stock on Jun 13, 2024 at an average price of $4.999 for a total value of $14,997.
Director Parsons Erin purchased 5,260 shares of common stock on Jun 13, 2024 at an average price of $4.88 for a total value of $25,668.8.
Director Parsons Erin purchased 5,260 shares of common stock on Jun 13, 2024 at an average price of $4.88 for a total value of $25,668.8.
$Kiora Pharmaceuticals (KPRX.US)$ In the world of R/S’s lately. This is gettin a baby R/S! Earnings was very nice and who knows? It hit ATL/52wk low on Friday.That makes a big ole bottom! Hehehe! Likes me some bottoms. Lets see if the higher price from R/S can actually bring some interest from the market in the next few day post R/S? Have vol/price alerts set. If i see a proper chart set up? Ill give it a shot if it presents!![]()
1
2
$Kiora Pharmaceuticals (KPRX.US)$A parade of solid news but this stock does not pop. I guess institutions have not adopted this stock. I can only guess.
$Kiora Pharmaceuticals (KPRX.US)$
NEWS
Kiora Pharmaceuticals Reports Additional Clinical Data for KIO-301 Showing a Statistically Significant Increase in Brain Activity in the Visual Cortex in Patients with Retinitis Pigmentosa
NEWS
Kiora Pharmaceuticals Reports Additional Clinical Data for KIO-301 Showing a Statistically Significant Increase in Brain Activity in the Visual Cortex in Patients with Retinitis Pigmentosa
4
4
$Kiora Pharmaceuticals (KPRX.US)$ Kiora Pharmaceuticals Receives Grant from Choroideremia Research Foundation to Fund Novel Clinical Trial Endpoints for Inherited Retinal Diseases; Approval Granted to Initiate Clinical Validation Study
Thu, Apr 11, 2024
Encinitas, California--(Newsfile Corp. - April 11, 2024) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) has received grant funding from the Choroideremia Research Foundation (CRF) in support of validating functional vision assessments for pat...
Thu, Apr 11, 2024
Encinitas, California--(Newsfile Corp. - April 11, 2024) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) has received grant funding from the Choroideremia Research Foundation (CRF) in support of validating functional vision assessments for pat...
1
$Kiora Pharmaceuticals (KPRX.US)$ Kiora Announces Publication of Phase 1 Study Demonstrating Safety, Tolerability and Anti-Inflammatory Activity of KIO-101 in the Treatment of Inflammation of the Eye
newsfile· 6 mins ago
newsfile· 6 mins ago
$Kiora Pharmaceuticals (KPRX.US)$ very low volume, looks like people have lost interest in this.
$Kiora Pharmaceuticals (KPRX.US)$ looking good, slow and up
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
发达发达 : Form 4 is a good news right?
Trytosaveabit OP 发达发达 : This for 4 is because it was a open market buy!
发达发达 Trytosaveabit OP : Appreciate your explanation.![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")